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Due to the intensive impact of chemicals on the environment, human populations and 
all living organisms have been exposed to various kinds of chemical substances. The 
number of new chemical compounds produced every year keeps increasing. Many of 
these so called xenobiotics are highly active substances and may have a significant effect 
on the living system. After entering the body system, they can affect many biochemical 
and physiological processes. In the case of new drugs, the effects should be desirable, 
i.e. protective and/or curative. However, the use of drugs, depending on their dose, may 
exhibit also undesirable and even toxic effects. It is therefore inevitable to investigate 
not only the effects of drugs and their fate in the organism (pharmacodynamics and 
pharmacokinetics) but also to assess their possible unfavorable influences on the living 
system (toxicology). In the case of industrial chemicals emitted to the environment, as 
well as chemical substances used in working places, households, it is essential to evalu-
ate their potential toxic effects on humans, animals and plants. Recent pharmacology 
and toxicology must challenge the increasing demands of the society for safe drugs 
and other chemicals used by humans. This requires close cooperation of pharmacolo-
gists and toxicologists from the academic and industrial sphere as well as professionals 
from the field of regulatory toxicology and legislation. Up-to-date approaches and 
techniques have to be utilized in preclinical and safety assessment studies. Due to the 
tens of thousands of new chemical substances produced, low- and medium-through-
put tests will have to be replaced eventually by high-through-put alternative methods 
using lower vertebrates, non-vertebrates or in vitro studies. 
The state of the art and development of pharmacology and toxicology in the Slovak 
Academy  of  Sciences  and  Universities  in  Slovakia  is  presented  in  this  issue  of 
Interdisciplinary Toxicology. Individual articles are proceedings of the lectures given 
at the symposium “Recent Slovak Pharmacology and Toxicology” held on April 5, 2011, 
at the campus of the Slovak Academy of Sciences in Bratislava. The papers are focused 
on pharmacological modulation of the activity of phagocytes and neutrophils, immu-
nobiological properties of modified polyphenols and isoprenoids, on the regulation 
of immunity and oxidative stress in the model of rheumatoid arthritis, they further 
concern studies of effects and safety of original pyridoindoles, experimental model 
of metabolic syndrome, the pharmacologic modulation of allergic asthma, as well as 
vascular pharmacology and protection of the endothelium in experimental conditions. 
Many results presented have been achieved in close cooperation with Czech scientists. 
The symposium and the issue of the Journal are dedicated to the birthday anniversary 
of the outstanding Slovak pharmacologist, Professor Radomír Nosáľ, MD., DSc., a 
founder and key personality in cell pharmacology in Slovakia, as well in the former 
Czecho-Slovakia. He is a great propagator and supporter of toxicology in Slovakia.
The Editorial Board wishes to Professor Radomír Nosaľ many happy returns of the day 
and much further success. 
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